Updates ·
Health notices · Wednesday 9 September
3 notices from the agencies today, in plain words, each with the original linked.
FreshPoint recalls chicken salad wedge sandwiches due to egg allergen
CDC · Food safety
The Centers for Disease Control and Prevention reports that FreshPoint of Orlando, Florida is issuing a voluntary recall of Cranberry Chicken Salad Wedge sandwiches from specific lots.
The issue is an improperly declared allergen: eggs. If you have an allergy or severe sensitivity to eggs, eating these sandwiches could put you at risk of serious harm.
The recall is tied to sandwiches distributed in Orlando, Florida, and involves 1,093 recalled units. Check the product and lot details in the recall notice if you received them.
Ebola outbreak with Bundibugyo virus continues in DR Congo and Uganda
World Health Organization (WHO) · Outbreak
If you are in the Democratic Republic of the Congo or Uganda, you may be affected. WHO says the Ebola disease caused by Bundibugyo virus outbreak is evolving rapidly, with increasing cases and spread.
As of 6 June, WHO reports 515 confirmed cases and 91 deaths among confirmed cases in the Democratic Republic of the Congo. Uganda has reported 19 confirmed cases, with two deaths, and one probable case who has died.
WHO says transmission is linked to infections originating in the Democratic Republic of the Congo, including imported infections and secondary spread among contacts and healthcare workers. National authorities, WHO, and partners are responding with a preparedness and response plan.
FDA approval for pomalidomide capsules for two conditions
Food and Drug Administration (FDA) · Approval
If you have multiple myeloma, a cancer of plasma cells, and your disease has progressed after at least two prior therapies (including lenalidomide and a proteasome inhibitor), the FDA approval adds pomalidomide in combination with dexamethasone as a treatment option.
If you have Kaposi sarcoma, a cancer linked to certain immune conditions, pomalidomide is approved for adults with AIDS-related Kaposi sarcoma after HAART has failed, or for Kaposi sarcoma in adults who are HIV-negative.